Phase 4 Osteoporosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women who have been through menopause for at least two years
- Women aged 40 years or older
- Women whose bone density scan results show a T-score of -2.0 or higher (meaning bone density is not severely low)
- Women who have at least two lower spine bones that can be measured by a special bone density scan called a DXA scan
- Women who have been diagnosed with type 2 diabetes
- Women who are taking metformin as their only diabetes medication
Who may not be able to join:
- People who have ever been treated for osteoporosis at any point in their life
- People who take any diabetes medication other than metformin
- People who have ever had a spinal fracture caused by a minor force or injury (such as a fall from standing height)
- People who have ever had a hip fracture caused by a minor force or injury
- People who are currently taking steroid tablets or other systemic steroid medications on an ongoing basis
- People who have a bone metabolism condition, such as brittle bone disease, Paget's disease of bone, or overactive parathyroid glands
- People who are taking any medication or treatment that affects bone strength, calcium levels, or muscle function
- People who have had an active cancer diagnosis within the last five years, except for a type of minor skin cancer called basal cell carcinoma
- People whose kidneys are not filtering blood well enough, based on a blood test result showing eGFR at or below 35 mL/min (confirm with trial site)
- People who are not able to read and understand Danish
- People who have limited mobility or are unable to move around independently
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bente Langdahl, MD, Professor, DMSc, PhD, Aarhus University Hospital
Phone: +45 22 30 05 24
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Insulin sensitivity: HbA1c; Insulin sensitivity: HOMA-IR; Insulin sensitivity: fasting glucose; Insulin sensitivity: oral glucose tolerance test; Muscle mass; Muscle strength
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.